Table 7. Cross-sectional associations between inflammation-related diseases and GlycA and hsCRP in UKB.
Variable | Model 1 | Model 2* | Model 3 ** (n=91245) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Beta (se) | 95% CI | p | Beta (se) | 95% CI | p | Beta (se) | 95% CI | p | ||
CRP | ||||||||||
Arthritis | 0.01 (0.0003) | 0.009, 0.01 | <0.001 | 0.01 (0.0003) | 0.008, 0.01 | <0.001 | 0.01 (0.0004) | 0.008, 0.01 | <0.001 | |
Asthma | 0.02 (0.001) | 0.020, 0.023 | <0.001 | 0.02 (0.001) | 0.019, 0.023 | <0.001 | 0.01 (0.001) | 0.01, 0.02 | <0.001 | |
Systemic Lupus Erthematosis | 0.0001 (0.0001) | -0.00001, 0.0002 | 0.0812 | 0.0001 (0.0001) | -0.0001, 0.0002 | 0.085 | 0.0001 (0.001) | -0.00003, 0.0002 | 0.120 | |
Multiple Sclerosis | 0.001 (0.0002) | 0.0005, 0.001 | <0.001 | 0.001 (0.0002) | 0.0005, 0.001 | <0.001 | 0.001 (0.0002) | 0.0003, 0.001 | 0.0003 | |
Sinusitis | 0.001 (0.0002) | 0.001, 0.002 | <0.001 | 0.001 (0.0002) | 0.001, 0.002 | <0.001 | 0.001 (0.0003) | 0.001, 0.002 | <0.001 | |
Diabetes | 0.03 (0.001) | 0.024, 0.027 | <0.001 | 0.03 (0.001) | 0.02, 0.024 | <0.001 | 0.0003 (0.001) | -0.001, 0.002 | 0.415 | |
Crohn’s disease | 0.002 (0.0002) | 0.002, 0.003 | <0.001 | 0.002 (0.0002) | 0.002, 0.003 | <0.001 | 0.003 (0.0002) | 0.002, 0.003 | <0.001 | |
Eczema | 0.001 (0.0002) | 0.001, 0.002 | <0.001 | 0.001 (0.0002) | 0.001, 0.002 | 0.001 | 0.001 (0.0002) | 0.0004, 0.001 | <0.001 | |
Hepatitis C. | 0.00003 (0.0001) | -0.0001, 0.0002 | 0.691 | 0.0001 (0.0001) | -0.0001, 0.0002 | 0.420 | 0.0001 (0.0001) | -0.0001, 0.0003 | 0.148 | |
Clusters | ||||||||||
Atopy | 0.02 (0.001) | 0.02, 0.03 | < 0.001 | 0.02 (0.001) | 0.021, 0.024 | < 0.001 | 0.01 (0.001) | 0.01, 0.02 | <0.001 | |
Infection | 0.001 (0.0003) | 0.001, 0.002 | < 0.001 | 0.001 (0.0003) | 0.001, 0.002 | <0.001 | 0.001 (0.003) | 0.001, 0.002 | <0.001 | |
Autoimmune | 0.04 (0.001) | 0.039, 0.042 | < 0.001 | 0.04 (0.001) | 0.036, 0.040 | <0.001 | 0.01 (0.001) | 0.01, 0.02 | <0.001 | |
GlycA | ||||||||||
Arthritis | 0.01 (0.0003) | 0.006, 0.007 | <0.001 | 0.01 (0.0003) | 0.005, 0.007 | <0.001 | 0.005 (0.0004) | 0.004, 0.01 | <0.001 | |
Asthma | 0.02 (0.001) | 0.016, 0.02 | <0.001 | 0.02 (0.001) | 0.015, 0.02 | <0.001 | 0.01 (0.001) | 0.007, 0.01 | <0.001 | |
Systemic Lupus Erthematosis | 0.0001 (0.0001) | -0.0001, 0.0002 | 0.334 | 0.0001 (0.0001) | -0.0001, 0.0002 | 0.323 | 0.0001 (0.0001) | -0.0001, 0.0002 | 0.417 | |
Multiple Sclerosis | 0.001 (0.0002) | 0.0003, 0.001 | 0.0001 | 0.001 (0.0002) | 0.0004, 0.001 | <0.001 | 0.001 (0.0002) | 0.0002, 0.001 | 0.002 | |
Sinusitis | 0.001 (0.0002) | 0.0005, 0.001 | 0.0001 | 0.001 (0.0002) | 0.0004, 0.001 | <0.001 | 0.001 (0.0003) | 0.0003, 0.001 | 0.002 | |
Diabetes | 0.03 (0.001) | 0.027, 0.03 | <0.001 | 0.03 (0.001) | 0.02, 0.03 | <0.001 | 0.01 (0.001) | 0.007, 0.01 | <0.001 | |
Chron’s disease | 0.002 (0.0002) | 0.002, 0.003 | <0.001 | 0.002 (0.0002) | 0.002, 0.003 | <0.001 | 0.003 (0.0002) | 0.002, 0.003 | <0.001 | |
Eczema | 0.001 (0.0002) | 0.0003, 0.001 | 0.0004 | 0.001 (0.0002) | 0.001, 0.003 | 0.001 | 0.0003 (0.0002) | -0.0002, 0.001 | 0.261 | |
Hepatitis C. | 0.00001 (0.0001) | -0.0002. 0.0002 | 0.881 | 0.00004 (0.0001) | -0.0001, 0.0002 | 0.625 | 0.0001 (0.0001) | -0.0001, 0.0002 | 0.493 | |
Clusters | ||||||||||
Atopy | 0.02 (0.001) | 0.016, 0.02 | < 0.001 | 0.02 (0.001) | 0.016, 0.019 | <0.001 | 0.01 (0.001) | 0.007, 0.01 | <0.001 | |
Infection | 0.001 (0.0003) | 0.0005, 0.001 | < 0.001 | 0.001 (0.0003) | 0.0005, 0.002 | <0.001 | 0.001 (0.003) | 0.0003, 0.001 | 0.002 | |
Autoimmune | 0.04 (0.001) | 0.04, 0.042 | < 0.001 | 0.04 (0.001) | 0.03, 0.04 | <0.001 | 0.02 (0.001) | 0.01, 0.02 | <0.001 |
Adjusted for age and sex
Adjusted for age, sex, SEP, BMI, ethnicity, smoking status, and drinking status.